← Eichor
Study identifier: NCT06982417 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

InsightRP2 Registry

Condition: RP2-associated Retinitis Pigmentosa · X-Linked Retinitis Pigmentosa (XLRP) · Retinitis Pigmentosa 2  ·  Sponsor: University of Göttingen

PhaseN/A
Planned participants200
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

InsightRP2 is a secure online patient registry specific to RP2-associated retinitis pigmentosa (RP). It is our goal to further the scientific understanding of this rare disease and to support research in to a gene therapy for RP2-associated RP. We collect medical, genetic and imaging data from people affected by RP2-associated RP and will coduct a natural history study as well as image analysis studies.

This description comes directly from the study's public registry record.

Talk to the study team

Nina Bögershausen, MD  ·  +49 (0)551 / 39-69016  ·  insight.rp2@med.uni-goettingen.de

Bernd Wollnik, MD, Prof.  ·  +49 (0)551 / 39-67589  ·  insight.rp2@med.uni-goettingen.de

Always discuss trial participation with your own doctor first.

Locations (1)

University Medicine GöttingenGöttingen, Lower Saxony, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06982417